Ziresovir Shows Promise in Alleviating Bronchiolitis Symptoms in Hospitalized Infants with RSV: Study Medha Baranwal28 Sept 2024 12:45 AM ISTChina: In a promising development for pediatric care, a recent study has highlighted the efficacy of Ziresovir in treating infants hospitalized due to...
Moderna forecasts lower sales next year, shares near four-year low MD Bureau Team14 Sept 2024 11:34 AM ISTLondon: Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key products and predicted...
CDSCO Panel Approves Pfizer's Protocol Amendment Proposal for antimicrobial drug Sisunatovir study Dr. Divya Colin9 Sept 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
New RSV vaccine can result in individual and societal cost savings, benefits for elderly: Study Dr. Kamal Kant Kohli6 Sept 2024 8:30 PM ISTVaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of...
Sanofi gets CDSCO marketing nod for RSV treatment Beyfortus in India Ruchika Sharma1 Aug 2024 5:30 PM ISTDrugmaker, Sanofi India, has received marketing authorisation approval from the Central Drugs Standard Control Organisation (CDSCO) for Beyfortus in...
New JAMA study backs RSV vaccine safety during pregnancy Dr. Kamal Kant Kohli10 July 2024 4:00 AM ISTVaccinating mothers against respiratory syncytial virus (RSV) during late pregnancy to protect their newborns is not associated with an increased risk...
GSK pharma Gets CDSCO Panel Nod To study Respiratory Syncytial Virus vaccine RSVPreF3 OA Dr. Divya Colin10 Jun 2024 6:00 PM ISTNew Delhi: Advising to include clinical trial sites from various states in the southern part of India, the Subject Expert Committee (SEC) functional...
USFDA grants Emergency Use Authorization for Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV Ruchika Sharma10 Jun 2024 3:26 PM ISTBasel: Roche announced today that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA)for its cobas liat...
New tool may help identify infants at high risk for poor RSV outcomes, reveals study Dr. Kamal Kant Kohli24 May 2024 7:30 AM ISTOn the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, a new tool...
Nirsevimab use may reduce infant hospitalizations due to RSV by 82 percent: Lancet Dr. Kamal Kant Kohli3 May 2024 7:00 PM ISTNirsevimab use may reduce infant hospitalizations due to respiratory syncytial virus (RSV) by 82 percent, shows real world evidence published in The...
Contracting RSV Before Age 2 Can Cause Long-term Lung Changes and functional Impairment, finds study Dr. Kamal Kant Kohli25 April 2024 10:00 AM ISTInfants and children who have severe cases of respiratory syncytial virus (RSV) before age 2 are likely to have changes to their lung structure and...
Respiratory syncytial virus has increased frequency of transplacental transmission in Pregnant Women: Study Jacinthlyn Sylvia12 April 2024 9:00 AM ISTA recent comprehensive study illuminated the transmission of respiratory viral infections from pregnant women to their offspring. This research...
